Berenberg raises target price on AstraZeneca
9th Jul 2025 09:01
(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker AstraZeneca from £140 to £142 per share on Wednesday, citing "strong pipeline readouts" which were yet to be reflected in its share price.
Read moreSunday newspaper round-up: Trade, AstraZeneca, Tax hikes
6th Jul 2025 12:41
(Sharecast News) - Brussels is heading into a critical week, with just two to go to clinch a trade agreement with the US or face a 50% levy on its exports. At stake are €1.6trn in transatlantic trade. Germany is down as favouring a quick deal akin to that inked by the UK so as to avoid a full-blown trade war. Paris on the other hand believes that the EU should hold out if too quick a deal is "imbalanced" - Guardian
Read moreLondon close: FTSE finishes flat ahead of Trump tariff deadline
4th Jul 2025 17:48
(Sharecast News) - London stocks ended Thursday little changed at the top tier but weaker further down the board, as investors weighed fresh economic data and cautious sentiment ahead of Donald Trump's 9 July tariff deadline next week.
Read moreAstraZeneca's Imfinzi gets EU green light
4th Jul 2025 07:10
(Sharecast News) - Drugmaker AstraZeneca said on Friday that its Imfinzi asset has been approved in the EU as the first and only perioperative immunotherapy for muscle-invasive bladder cancer.
Read moreAstraZeneca's Datroway gets green light from FDA
24th Jun 2025 07:10
(Sharecast News) - Drugmaker AstraZeneca's Datroway has been approved in the US for adult patients with previously treated advanced EGFR-mutated non-small cell lung cancer.
Read moreAstraZeneca launches strategic research collaboration with China's CSPC Pharmaceuticals
13th Jun 2025 09:51
(Sharecast News) - Drugmaker AstraZeneca revealed on Friday that it has entered a strategic research collaboration with Chinese firm CSPC Pharmaceuticals Group.
Read moreAstraZeneca's Calquence receives European Commission approval
6th Jun 2025 08:05
(Sharecast News) - Drugmaker AstraZeneca said on Friday that it had received approval from the European Commission for fixed-duration regimens of its chronic lymphocytic leukaemia candidate Calquence in a first-line setting.
Read moreEU recommends AstraZeneca bladder cancer treatment for approval
27th May 2025 08:36
(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).
Read moreLondon close: Stocks finish choppy week in the black
16th May 2025 16:32
(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.
Read moreLondon close: Stocks rally on US-China tariff deal
12th May 2025 16:30
(Sharecast News) - London stocks ended higher on Monday as investors welcomed news of a temporary trade agreement between the United States and China that will see a rollback of some tariffs.
Read morePharma stocks slide as Trump threatens price cuts in US
12th May 2025 10:13
(Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash the price of prescription drugs for Americans.
Read moreSunday newspaper round-up: US-China, Aerospace, Pharma
11th May 2025 14:38
(Sharecast News) - The US president said talks with China that were taking place in Geneva had achieved a "total reset" in the two countries' trade relations. Without elaborating, Donald Trump said that great progress had been made and that they wanted to see an opening up of China to American businesses. The negotiations were scheduled to continue on Sunday. - Guardian
Read moreLondon close: FTSE snaps 16-day win streak ahead of Fed
7th May 2025 15:05
(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the US Federal Reserve's policy decision weighed on sentiment.
Read moreGSK, AstraZeneca slide after FDA unveils new vaccine lead
7th May 2025 11:32
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Read moreAstraZeneca receives 'positive high-level results' results from Enhertu trial
7th May 2025 09:23
(Sharecast News) - Drugmaker AstraZeneca revealed on Wednesday that it had received "positive high-level results" from a Phase III trial on its specifically engineered HER2-directed DXd antibody drug conjugate Enhertu.
Read more